Back
KraneShares Emerging Markets Consumer Tech Idx ETF Vs. United Therapeutics Industry Stock Comparison
Buy
81
KEMQ
KraneShares Emerging Markets Consumer Tech Idx ETF
Last Price:
$22.35
Seasonality Move:
-4.95%
Buy
54
UTHR
United Therapeutics
Last Price:
$295.33
Seasonality Move:
8.9%
Buy
81
KraneShares Emerging Markets Consumer Tech Idx ETF (KEMQ)
is a Buy
Is KraneShares Emerging Markets Consumer Tech Idx ETF a Buy, Sell or Hold?
-
The current KraneShares Emerging Markets Consumer Tech Idx ETF [KEMQ] share price is $22.23. The Score for KEMQ is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
-
KEMQ is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
54
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy, Sell or Hold?
-
The current United Therapeutics [UTHR] share price is $295.22. The Score for UTHR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KEMQ Stock Price Chart
What is KraneShares Emerging Markets Consumer Tech Idx ETF's stock price today?
-
The KraneShares Emerging Markets Consumer Tech Idx ETF share price today is $22.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KEMQ is experiencing buying pressure, which is a positive indicator for future bullish movement.
UTHR Stock Price Chart
What is United Therapeutics's stock price today?
-
The United Therapeutics share price today is $295.22Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
KEMQ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.12 | Buy |
Relative Strength Index (14 RSI): | 63.94 | Buy |
Chaikin Money Flow: | 5576 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.6 - 22.2) | Buy |
Bollinger Bands (100): | (18.28 - 21.04) | Buy |
UTHR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Sell |
Relative Strength Index (14 RSI): | 49.75 | Sell |
Chaikin Money Flow: | 298346 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
KEMQ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.33 | Sell |
20-day SMA: | 21.71 | Buy |
50-day SMA: | 20.43 | Buy |
200-day SMA: | 18.63 | Buy |
8-day EMA: | 22.08 | Buy |
20-day EMA: | 19.01 | Buy |
50-day EMA: | 12.02 | Buy |
200-day EMA: | 3.94 | Buy |
UTHR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0 | Buy |
20-day SMA: | 0 | Buy |
50-day SMA: | 0 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 0 | Buy |
20-day EMA: | 0 | Buy |
50-day EMA: | 0 | Buy |
200-day EMA: | 0 | Buy |
KraneShares Emerging Markets Consumer Tech Idx ETF Earnings Growth & KEMQ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
United Therapeutics Earnings Growth & UTHR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.15 per share, an increase this year of $2.52 per share, and an increase next year of $0.95 per share.
KraneShares Emerging Markets Consumer Tech Idx ETF Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
United Therapeutics Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |